Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Type I Hypersensitivity
Interventions: TreeMATA MPL; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 10
States / cities: Mission Viejo, California • San Jose, California • Woodstock, Georgia + 7 more

Conditions: Melanoma, Survivors, Psychological Factors
Interventions: Focus group, Survey; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer's Disease
Interventions: Home based occupational therapy, Best practices primary care; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 45 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Asthma, Aspirin-Induced
Interventions: Ifetroban Oral Capsule, Placebo Oral Capsule; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 16
States / cities: Tucson, Arizona • Lancaster, California • San Diego, California + 13 more

Conditions: Anthrax
Interventions: AIGIV 3.5 mg/kg, Gamunex 90 mg/kg, AIGIV 7.0 mg/kg, Gamunex 180 mg/kg, AIGIV 14.0 mg/kg, Gamunex 360 mg/kg; Biological
Lead sponsor: Emergent BioSolutions; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cognition Disorder, Healthy
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 1 Year to 3 Years
Enrollment: 219 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Brain Tumor
Interventions: Interstitial Laser Therapy; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anorexia Nervosa
Interventions: Hormone replacement therapy (estrogen/progestin), Placebo (Sugar Pill), Dehydroepiandrosterone (DHEA); Drug · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 15 Years to 30 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Periodontal Diseases
Interventions: Methylcellulose, Simvastatin-Methylcellulose; Other · Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 40 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome/Acute Myeloid Leukemia
Interventions: Azacitidine, Cytarabine, Decitabine, Laboratory Biomarker Analysis, Midostaurin, Nivolumab; Drug · Other · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 60 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 506
States / cities: Anchorage, Alaska • Tucson, Arizona • Hot Springs, Arkansas + 337 more

Conditions: Bereavement
Interventions: Digital Storytelling; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Nolensville, Tennessee

Conditions: Parkinson Disease
Interventions: Barre exercise; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mammoplasty, Postoperative Pain
Interventions: Instillation - EXPAREL, Infiltration - EXPAREL; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: HIV Infections, Depression
Interventions: Telephone-administered coping improvement therapy, Telephone-administered supportive-expressive therapy, Individual therapy; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 50 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Long COVID, Long Covid19, Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Long Haul COVID, Long-Haul COVID-19
Interventions: Endourage Targeted Wellness Formula C™, a full hemp flower extract; Combination Product
Lead sponsor: Endourage, LLC; Industry
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Relapsing-remitting Multiple Sclerosis
Interventions: Motivational Interviewing-Cognitive Behavioral Therapy, Brief Education; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Kansas City, Missouri • West Orange, New Jersey

Conditions: Dental Caries
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 9 Months to 15 Months
Enrollment: 1,326 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 3
States / cities: Indianapolis, Indiana • Iowa City, Iowa • Durham, North Carolina

Conditions: Healthy
Interventions: Intravenous ethanol placebo plus nicotine infusions, intravenous ethanol 40mg% plus nicotine infusions, intravenous ethanol 100mg% plus nicotine infusions; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 50 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Gaucher's Disease
Interventions: Lysodase; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Low Back Pain
Interventions: Lumbar traction; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Lead Poisoning
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Depressive Symptoms, Anxiety, Sleep, Emotion Regulation, Pain, Military Operations, Cohesion, Social, Mindfulness, Yoga, Leadership, Health, Subjective, Stress, Mood, Musculoskeletal Injury
Interventions: Mindfulness Based Attention Training (MBAT) and Yoga; Behavioral
Lead sponsor: Walter Reed Army Institute of Research (WRAIR); Federal
Eligibility: 17 Years and older
Enrollment: 1,896 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Fort Jackson, South Carolina

Conditions: Ankle Sprain
Interventions: Fibular Taping, Sham Taping; Other
Lead sponsor: Creighton University; Other
Eligibility: 16 Years to 45 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Malaria Prophylaxis
Interventions: azithromycin (AZ) microsphere, test chloroquine (CQ) formulation, azithromycin (AZ), chloroquine (CQ); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Alzheimer's Disease Multiple Intervention Trial

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The Development of Categorization

Neurosurgical Use of Interstitial Laser Therapy (ILT)

Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

Effect of Locally-Applied Simvastatin on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Digital Storytelling in the NICU

Barre Exercise in Parkinson's

Study of EXPAREL in Patients Undergoing Breast Augmentation

Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV

Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops

Development of a Motivational Intervention to Improve Treatment Adherence in MS

Predicting Caries Risk in Underserved Toddlers in Primary Healthcare Settings

Interactive Effects of IV Ethanol and IV Nicotine

PEG-Glucocerebrosidase for the Treatment of Gaucher Disease

Predictive Validity of Lumbopelvic Stress Tests to Determine Those Who Will Benefit From Lumbar Traction: A Pilot Study

Early Exposure to Lead and Adult Antisocial Outcomes

Evaluation of Mindfulness and Yoga in Basic Combat Training

Effects of Ankle Support on Muscle Activation and Function

A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects